Kisunla

Donanemab-azbt · Eli Lilly and Company
PRESCRIPTION ONLY (USA)

Kisunla ingredients

Active ingredientStrength
Donanemab17.5 mg/mL

What Kisunla is used for

Kisunla is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Kisunla
Generic name
Donanemab-azbt
Made by
Eli Lilly and Company
Forms
Injection, Solution
Given
Intravenous
FDA approval
Biologic licence (BLA) BLA761248
On the US market since
2024

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Kisunla?

Kisunla (Donanemab-azbt) is a specialist medicine made by Eli Lilly and Company, approved by the US FDA.

What are the ingredients of Kisunla?

Kisunla contains Donanemab (17.5 mg/mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.